Results 81 to 90 of about 446,438 (288)

Anomaly Detection-Based UE-Centric Inter-Cell Interference Suppression

open access: yesIEEE Open Journal of the Communications Society
The increasing spectral reuse can cause significant performance degradation due to interference from neighboring cells. In such scenarios, developing effective interference suppression schemes is necessary to improve overall system performance. To tackle
Kwonyeol Park   +9 more
doaj   +1 more source

Projection Versus Prewhitening for EEG Interference Suppression [PDF]

open access: yesIEEE Transactions on Biomedical Engineering, 2012
Suppression of strong, spatially correlated background interference is a challenge associated with electroencephalography (EEG) source localization problems. The most common way of dealing with such interference is through the use of a prewhitening transformation based on an estimate of the covariance of the interference plus noise.
Shun Chi, Wu   +3 more
openaire   +2 more sources

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Interference Coupling Characteristics and Suppression of High-Power EMP for Satellite Power Systems

open access: yesSpace: Science & Technology
The transient intense high-power electromagnetic pulse radiation in space can have a serious impact on the normal operation of in-orbit satellites. Especially for satellite electrical power systems (EPSs), electromagnetic pulses will be coupled to the ...
Shuo Jiang   +6 more
doaj   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

An experimental SMI adaptive antenna array for weak interfering signals [PDF]

open access: yes
A modified sample matrix inversion (SMI) algorithm designed to increase the suppression of weak interference is implemented on an existing experimental array system.
Dilsavor, R. L., Gupta, I. J.
core   +1 more source

Sublattice Interference in the Kagome Hubbard Model

open access: yes, 2012
We study the electronic phases of the kagome Hubbard model (KHM) in the weak coupling limit around van Hove filling. Through an analytic renormalization group analysis, we find that there exists a sublattice interference mechanism where the kagome ...
G. Misguich   +2 more
core   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Magnetic field dependence of valley splitting in realistic Si/SiGe quantum wells

open access: yes, 2006
The authors investigate the magnetic field dependence of the energy splitting between low-lying valley states for electrons in a Si/SiGe quantum well tilted with respect to the crystallographic axis.
Coppersmith, S. N.   +2 more
core   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy